162 related articles for article (PubMed ID: 36334358)
61. Pathologically examining a minimum of three lymph nodes could better determine node negativity in patients with non-metastatic chromophobe renal cell carcinoma.
Dong F; Xu L; Peng X; Xu T; Shen Y; Gao F; Wang X; Zhang X; Chen S; Zhang M; Zhong S; Ding Q
Jpn J Clin Oncol; 2018 Oct; 48(10):942-949. PubMed ID: 30137442
[TBL] [Abstract][Full Text] [Related]
62. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
63. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?
Cserni G; Vinh-Hung V; Burzykowski T
J Surg Oncol; 2002 Oct; 81(2):63-9. PubMed ID: 12355405
[TBL] [Abstract][Full Text] [Related]
64. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
[TBL] [Abstract][Full Text] [Related]
65. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
[TBL] [Abstract][Full Text] [Related]
66. Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.
Rakislova N; Montironi C; Aldecoa I; Fernandez E; Bombi JA; Jimeno M; Balaguer F; Pellise M; Castells A; Cuatrecasas M
J Transl Med; 2017 Jan; 15(1):14. PubMed ID: 28088238
[TBL] [Abstract][Full Text] [Related]
67. Analysis of Lymph Node Sampling Minimums in Early Stage Non-Small-Cell Lung Cancer.
Dezube AR; Mazzola E; Bravo-Iñiguez CE; De León LE; Rochefort MM; Bueno R; Wiener DC; Jaklitsch MT;
Semin Thorac Cardiovasc Surg; 2021; 33(3):834-845. PubMed ID: 33181301
[TBL] [Abstract][Full Text] [Related]
68. Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model.
Hua J; Zhang B; Xu J; Liu J; Ni Q; He J; Zheng L; Yu X; Shi S
Eur J Surg Oncol; 2019 Jun; 45(6):1069-1076. PubMed ID: 30685327
[TBL] [Abstract][Full Text] [Related]
69. The Effect of Examined Lymph Nodes and Lymph Node Ratio on Pathological Nodal Classification in the Lung Adenosquamous Carcinoma After Lobectomy.
Feng S; Liu X; Huang B; Shi J; Zhang H
Front Surg; 2022; 9():909810. PubMed ID: 35756483
[TBL] [Abstract][Full Text] [Related]
70. Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
Samayoa AX; Pezzi TA; Pezzi CM; Greer Gay E; Asai M; Kulkarni N; Carp N; Chun SG; Putnam JB
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1005-1011. PubMed ID: 27531307
[TBL] [Abstract][Full Text] [Related]
71. Nodes staging score to quantify lymph nodes for examination in gastric cancer.
Sun L; Liu Q; Ren H; Li P; Liu G; Sun L
Medicine (Baltimore); 2020 Aug; 99(33):e21085. PubMed ID: 32871979
[TBL] [Abstract][Full Text] [Related]
72. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
[TBL] [Abstract][Full Text] [Related]
73. Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.
Wo Y; Zhao Y; Qiu T; Li S; Wang Y; Lu T; Qin Y; Song G; Miao S; Sun X; Liu A; Kong D; Dong Y; Leng X; Du W; Jiao W
Cancer Med; 2019 Feb; 8(2):669-678. PubMed ID: 30706688
[TBL] [Abstract][Full Text] [Related]
74. On the probability of lymph node negativity in pN0-staged prostate cancer-a theoretically derived rule of thumb for adjuvant needs.
Paulsen F; Bedke J; Wegener D; Marzec J; Martus P; Nann D; Stenzl A; Zips D; Müller AC
Strahlenther Onkol; 2022 Aug; 198(8):690-699. PubMed ID: 34476527
[TBL] [Abstract][Full Text] [Related]
75. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
76. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
[TBL] [Abstract][Full Text] [Related]
77. Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer.
Ho AS; Kim S; Tighiouart M; Gudino C; Mita A; Scher KS; Laury A; Prasad R; Shiao SL; Ali N; Patio C; Mallen-St Clair J; Van Eyk JE; Zumsteg ZS
JAMA Oncol; 2018 Jul; 4(7):985-989. PubMed ID: 29192305
[TBL] [Abstract][Full Text] [Related]
78. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
79. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases.
Benlloch S; Galbis-Caravajal JM; Alenda C; Peiró FM; Sanchez-Ronco M; Rodríguez-Paniagua JM; Baschwitz B; Rojas E; Massutí B
Ann Oncol; 2009 Jan; 20(1):91-7. PubMed ID: 18664559
[TBL] [Abstract][Full Text] [Related]
80. Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer.
Osarogiagbon RU; Ogbata O; Yu X
Ann Thorac Surg; 2014 Feb; 97(2):385-93. PubMed ID: 24266949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
